1. Home
  2. ASB vs DNTH Comparison

ASB vs DNTH Comparison

Compare ASB & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Associated Banc-Corp

ASB

Associated Banc-Corp

HOLD

Current Price

$27.77

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$90.65

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASB
DNTH
Founded
1861
2015
Country
United States
United States
Employees
4000
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.6B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ASB
DNTH
Price
$27.77
$90.65
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
$29.75
$121.00
AVG Volume (30 Days)
1.5M
425.6K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,036,000.00
Revenue This Year
$21.24
N/A
Revenue Next Year
$8.86
$29.48
P/E Ratio
$10.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.48
$16.77
52 Week High
$29.52
$96.50

Technical Indicators

Market Signals
Indicator
ASB
DNTH
Relative Strength Index (RSI) 50.25 59.23
Support Level $27.15 $81.16
Resistance Level $28.02 $96.50
Average True Range (ATR) 0.54 4.45
MACD -0.04 0.25
Stochastic Oscillator 42.90 85.05

Price Performance

Historical Comparison
ASB
DNTH

About ASB Associated Banc-Corp

Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: